Cite
HARVARD Citation
Zhu, J. et al. (2022). Clinical Relevance and Tumor Growth Suppression of Mitochondrial ROS Regulators along NADH:Ubiquinone Oxidoreductase Subunit B3 in Thyroid Cancer. Oxidative medicine and cellular longevity. p. . [Online].